Inventor · disambiguated record
Huajie Zhang
Also filed as: ZHANG HUAJIE
10 granted patents·6 pending applications·29 citations·filing 2005–2023
83Inventor score
Files withFOCHON BIOSCIENCES LTD4FOCHON PHARMACEUTICALS LTD3SHANGHAI FOCHON PHARMACEUTICAL CO LTD3NINGBO BABYTEC MATERNAL & INFANT TECH CO LTD1NINGBO WINBAY TECH CO LTD1
Top patents by PatentIndex Score
16 records- 0188USD975945SLeaf blowerNINGBO BABYTEC MATERNAL & INFANT TECH CO LTD·Filed 2022·Granted Jan 17, 2023·13 cites·1 claims
- 0287US11053239B2Compounds as BLC-2-selective apoptosis-inducing agentsFOCHON PHARMACEUTICALS LTD·Filed 2018·Granted Jul 6, 2021·6 cites·13 claims
- 0378US11091478B2Apoptosis-inducing agentsFOCHON PHARMACEUTICALS LTD·Filed 2018·Granted Aug 17, 2021·2 cites·32 claims
- 0477USD1011661SLeaf blowerNINGBO WINBAY TECH CO LTD·Filed 2023·Granted Jan 16, 2024·6 cites·1 claims
- 0573US10087195B2Certain protein kinase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2015·Granted Oct 2, 2018·2 cites·14 claims
- 0660US12312349B2Apoptosis-inducing agentsFOCHON PHARMACEUTICALS LTD·Filed 2021·Granted May 27, 2025·0 cites·16 claims
- 0753US2024429703A1Method and system for protecting high-voltage direct-current line, device and storage mediumSTATE GRID SICHUAN ELECTRIC POWER RES INSTITUTE·Filed 2023·Application pending·0 cites
- 0848US2023174556A1Compounds as protein kinase inhibitorsFOCHON BIOSCIENCES LTD·Filed 2021·Application pending·0 cites
- 0947US2023135215A1Compounds as cdk2/4/6 inhibitorsFOCHON BIOSCIENCES LTD·Filed 2021·Application pending·0 cites
- 1046US2023145305A1Compounds useful as kinase inhibitorsFOCHON BIOSCIENCES LTD·Filed 2021·Application pending·0 cites
- 1145US10209135B2Method for measuring multi-channel mismatch of ultra-high speed photonic sampler and measurement compensation device thereofUNIV SHANGHAI JIAOTONG·Filed 2014·Granted Feb 19, 2019·0 cites·2 claims
- 1242US7683073B2Isoquinoline-1,3,4-trione compounds, the synthetic method and the use thereofSHANGHAI INST MATERIA MEDICA·Filed 2005·Granted Mar 23, 2010·0 cites·9 claims
- 1340US2015284385A1Certain dipeptidyl peptidase inhibitorsSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2013·Application pending·0 cites
- 1436US11555042B2Macrocyclic compounds as TRK kinases inhibitorsFOCHON BIOSCIENCES LTD·Filed 2019·Granted Jan 17, 2023·0 cites·31 claims
- 1536US10894038B2Indolizine derivatives, composition and methods of useSHANGHAI FOCHON PHARMACEUTICAL CO LTD·Filed 2016·Granted Jan 19, 2021·0 cites·20 claims
- 1633US2016145244A1Certain protein kinase inhibitorsWANG WEIBO·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →